They found moderate to strong infiltration of IL-17-producing lymphocytes and macrophages in 20% of breast cancer samples, with a trend of association with estrogen receptor negative tumors (ER-), not reaching statistical significance, probably due to small numbers. This evidence concerns the gene ESR1 and breast cancer.